Cubist Systematic Strategies’s Akebia Therapeutics AKBA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$614K Buy
168,738
+160,903
+2,054% +$586K ﹤0.01% 999
2025
Q1
$15K Buy
+7,835
New +$15K ﹤0.01% 1355
2024
Q2
Sell
-398,247
Closed -$729K 1418
2024
Q1
$729K Buy
398,247
+330,620
+489% +$605K ﹤0.01% 1265
2023
Q4
$83.9K Buy
+67,627
New +$83.9K ﹤0.01% 1811
2023
Q1
Sell
-11,232
Closed -$6.48K 2812
2022
Q4
$6.48K Buy
+11,232
New +$6.48K ﹤0.01% 3111
2022
Q3
Sell
-18,295
Closed -$6K 3591
2022
Q2
$6K Buy
+18,295
New +$6K ﹤0.01% 3747
2022
Q1
Sell
-158,507
Closed -$358K 3511
2021
Q4
$358K Buy
158,507
+99,227
+167% +$224K ﹤0.01% 2680
2021
Q3
$171K Sell
59,280
-65,195
-52% -$188K ﹤0.01% 2627
2021
Q2
$472K Buy
124,475
+65,415
+111% +$248K 0.01% 2055
2021
Q1
$200K Buy
59,060
+34,143
+137% +$116K ﹤0.01% 2478
2020
Q4
$70K Sell
24,917
-8,342
-25% -$23.4K ﹤0.01% 2438
2020
Q3
$83K Sell
33,259
-59,441
-64% -$148K ﹤0.01% 2312
2020
Q2
$1.26M Buy
92,700
+22,094
+31% +$300K 0.02% 1055
2020
Q1
$535K Buy
70,606
+18,771
+36% +$142K 0.01% 1215
2019
Q4
$328K Buy
+51,835
New +$328K 0.01% 1802
2019
Q3
Sell
-61,000
Closed -$295K 2190
2019
Q2
$295K Sell
61,000
-8,010
-12% -$38.7K 0.01% 1813
2019
Q1
$565K Buy
69,010
+15,626
+29% +$128K 0.02% 1113
2018
Q4
$295K Buy
53,384
+51,855
+3,391% +$287K 0.01% 1288
2018
Q3
$14K Sell
1,529
-12,204
-89% -$112K ﹤0.01% 1790
2018
Q2
$137K Sell
13,733
-2,853
-17% -$28.5K 0.01% 1456
2018
Q1
$158K Buy
+16,586
New +$158K 0.01% 1484
2017
Q3
Sell
-11,038
Closed -$159K 1825
2017
Q2
$159K Buy
+11,038
New +$159K 0.01% 1353
2016
Q3
Sell
-694
Closed -$5K 1679
2016
Q2
$5K Sell
694
-1,911
-73% -$13.8K ﹤0.01% 1667
2016
Q1
$23K Sell
2,605
-24,916
-91% -$220K ﹤0.01% 1521
2015
Q4
$356K Buy
+27,521
New +$356K 0.02% 1014